Iksuda Therapeutics
Developer of biological therapeutics designed to target difficult-to-treat cancers, including those resistant or refractory to current therapies. The company's therapeutics are antibody-drug conjugate...
Valuation
$68.5M
Market implied
Share Price
N/A
Total Raised
$77.2M
Last Round
N/A